Security report for biochemtron.com
上海凯创生物技术有限公司 · Healthcare · China
High risk. 7 critical or high findings in SSL/TLS, Security headers and 2 other checks.
上海凯创生物技术有限公司是一家专注于体外诊断试剂和POCT快速诊断试剂研发、生产和销售的医疗器械企业,拥有20多年行业经验和多项国际认证。公司产品涵盖毒品检测、肿瘤检测、心血管疾病检测等多个领域,销往全球70多个国家和地区,市场定位稳固且具国际竞争力。技术基础包括使用多种前端技术和基于EmpireCMS的内容管理系统,网站设计专业且移动端优化良好。安全方面,网站启用了HTTPS但缺乏DNSSEC和高级安全头,且使用了较旧的JavaScript库,存在一定安全隐患。隐私合规方面,网站提供隐私政策但缺少cookie同意机制,存在GDPR合规风险。整体来看,网站内容丰富、业务信息透明,具备较高的商业可信度,但安全和隐私保护方面有提升空间。
Scanned
NIS2 and GDPR posture
- GDPR outside view
- 53/ 100 · Medium
- Checks completed
- 7of 7
NIS2 Art. 21(2)
- (a) Risk analysis and security policies: Not visible from outside
- (b) Incident handling: One indicator
- (c) Business continuity, backups and crisis management: Not visible from outside
- (d) Supply chain security: Not visible from outside
- (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
- (f) Assessing the effectiveness of security measures: Not visible from outside
- (g) Cyber hygiene and security training: Not visible from outside
- (h) Cryptography and encryption: Partly checked
- (i) HR security, access control and asset management: One indicator
- (j) Multi-factor authentication and secured communications: Not visible from outside
This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.
GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.
Priority findings
7 findings rated critical or high. Fix these first.
SSL/TLS
TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.
- Critical
Unable to retrieve SSL certificate
Could not establish secure connection to retrieve certificate information
What to do: Check if the server is accessible and SSL/TLS is properly configured
- Critical
Security headers
Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.
- High
Missing Strict-Transport-Security header
Forces HTTPS connections
What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"
- CWE-319
- OWASP A04:2025
- ASVS V3.4.1
- RFC 6797 §6.1.1
- Mozilla TLS: Mozilla Server Side TLS 6.0 intermediate: hsts_min_age 63072000
- NIS2 21(2)(h)
- IR 2024/2690 9.2(a): Implementing Regulation (EU) 2024/2690, Annex point 9.2(a): Cryptography
- NIST SC-8: NIST SP 800-53 Rev. 5 SC-8: Transmission Confidentiality and Integrity
- High
Missing X-Frame-Options header
Prevents clickjacking attacks
What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"
- CWE-1021
- OWASP A06:2025
- CAPEC-103
- ASVS V3.4.6
- OWASP Secure Headers: OWASP Secure Headers Project recommends X-Frame-Options: deny
- RFC 7034
- High
Missing Content-Security-Policy header
Controls resources the browser is allowed to load
What to do: Implement a Content-Security-Policy appropriate for your application
- ASVS V3.4.3
- OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…
- High
GDPR outside view
These are the privacy signals visitors and data protection authorities look for under GDPR.
- High
No Cookie Policy found
GDPR requires clear information about cookie usage
What to do: Add a dedicated cookie policy explaining cookie usage and purposes
- High
No Cookie Consent Banner found
GDPR requires explicit consent for non-essential cookies
What to do: Implement a cookie consent banner that appears on first visit
- GDPR Art. 7
- ePrivacy Art. 5(3)
- NIST PT-4: NIST SP 800-53 Rev. 5 PT-4: Consent
- High
Need hands-on remediation? Email guard@offseq.com
Keep watching biochemtron.com
This scan found 22 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.
Daily monitoring
Recommended€25per month
- TLS certificates and expiry
- DNS records
- SPF, DKIM and DMARC
- Security headers
- GDPR and NIS2 posture
- Exposed services
- Third-party trackers
- Security score drift
Email alerts on material changes and an exportable JSON history of every change.
Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.
Full report
€39.90one-time
- The complete analysis as a PDF you can cite
- Email delivery with an unlock code
- Lifetime access to this report
Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.
Results by check
Each check with its score, findings and the evidence it collected.
How this score is calculated
The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.
Counted in this score
- SSL/TLS
- 0
- Security headers
- 15
- Email security
- 70
- DNS health
- 85
- Network security
- 20
- GDPR outside view
- 53
- Average
- 41
Not counted
- NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
- OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.
Findings that cap the score at 49
Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.
- The certificate is not trusted by browsers
- The website is not served over HTTPS
- A database, remote desktop, file-sharing or Telnet service is reachable from the internet
- The page loads a script from a compromised source
- The domain registration has expired
- SPF authorises every server to send mail as the domain
Partial scans
When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.
Risk levels
- Critical0–25
- High26–49
- Medium50–75
- Low76–100
Technical appendix
Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.
Business context
Business profile
Security posture
Recommendations
- 启用DNSSEC以增强域名解析安全
- 配置安全HTTP头,如Content-Security-Policy和Strict-Transport-Security
- 升级jQuery及其他前端库至最新安全版本
- 增加cookie同意机制,完善隐私合规措施
- 建立安全事件响应和漏洞披露渠道,提升安全文化
Contact details published on the site
- Addresses
- Legal name
- 上海凯创生物技术有限公司
Site observations
Automated reading of the public site. Ratings are indicative.
Business
- Company
- 上海凯创生物技术有限公司
- Description
- 凯创公司专注于体外诊断试剂和POCT快速诊断试剂的研发、生产和销售,拥有20多年经验,产品涵盖毒品检测、心血管检测、慢性病防治诊断等多个领域,产品销往全球70多个国家和地区。
- Key services
- 体外诊断试剂研发, 快速诊断试剂生产, 检测设备制造, 技术支持与服务
- Content quality
- good
- Branding
- consistent
Technology
- Stack
- jQuery 1.10.2, Sea.js, BxSlider, WOW.js, FontAwesome
- Performance
- moderate
- Mobile
- good
- Accessibility
- basic
- SEO
- good
Security
- Observed score
- 60/100
- Good practices seen
- HTTPS enabled
- ClientDeleteProhibited domain status
Analytics and tracking
- Services
- Baidu Analytics, 360 Analytics
- Tracking level
- moderate
- Privacy practices
- basic
Advertising
- Tracking pixels
- Baidu Analytics, 360 Analytics
- Marketing tools
- Baidu push script, 360 push script
- Transparency
- basic
Site quality
- Design
- good
- User experience
- good
- Content relevance
- good
- Navigation
- good
- Professionalism
- good
- Trustworthiness
- high
Key observations
- Website is fully accessible with rich content in Chinese.
- Company is a medical diagnostics manufacturer with international certifications.
- No privacy or cookie consent banners detected, indicating potential GDPR compliance gaps.
- Use of older JavaScript libraries may pose security risks.
- No visible advanced security headers implemented.
- WHOIS data supports legitimacy and consistent business identity.
- Multiple external links to trusted partners and industry-related sites.
- Contact information is clearly presented with multiple channels.
Technical notes
Notes
Standards and sources
Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.
- MITRE CWE (opens in a new tab)4.20 (2026-04-30) · CWE Terms of Use (free use with attribution, © MITRE)
- OWASP Top 10:2025 (opens in a new tab)2025 (membership per CWE 4.20) · CC BY-SA 4.0
- MITRE CAPEC (opens in a new tab)3.9 (2023-01-24) · CAPEC Terms of Use (free use with attribution, © MITRE)
- OWASP ASVS (opens in a new tab)5.0.0 · CC BY-SA 4.0
- OWASP Web Security Testing Guide (opens in a new tab)latest (checklist.json, master) · CC BY-SA 4.0
- OWASP Secure Headers Project (opens in a new tab)2026-10-18 · Apache-2.0
- Mozilla Server Side TLS (intermediate) (opens in a new tab)6.0 · MPL-2.0
- NIST SP 800-53 Rev. 5 (OSCAL catalog) (opens in a new tab)5.2.0 · Public domain (US Government work)
- Directive (EU) 2022/2555 (NIS2) (opens in a new tab)OJ L 333, 27.12.2022 · EUR-Lex reuse under Commission Decision 2011/833/EU (© European Union)
- Commission Implementing Regulation (EU) 2024/2690 (opens in a new tab)OJ L, 18.10.2024 · EUR-Lex reuse under Commission Decision 2011/833/EU (© European Union)
- Regulation (EU) 2016/679 (GDPR) (opens in a new tab)OJ L 119, 4.5.2016 · EUR-Lex reuse under Commission Decision 2011/833/EU (© European Union)
- Directive 2002/58/EC (ePrivacy), consolidated (opens in a new tab)19.12.2009 · EUR-Lex reuse under Commission Decision 2011/833/EU (© European Union)
- RFC Editor metadata (opens in a new tab)per-RFC (obsolete RFCs rejected) · IETF Trust Legal Provisions (metadata only)
- NIST CSRC, W3C TR, IETF Datatracker, EDPB, EUR-Lex CELLAR and gesetze-bayern.de (opens in a new tab)per document · Titles and links only
- NIST NVD CVE API 2.0 (opens in a new tab)live records · Public domain (NVD); CVE® records © MITRE, free use
- W3C WCAG 2.2 (opens in a new tab)W3C Recommendation (wcag.json) · W3C Software and Document License
- ETSI EN 301 549 (opens in a new tab)V3.2.1 (2021-03), clause headings · Clause numbers and titles only (© ETSI)
- Directive (EU) 2019/882 (European Accessibility Act) (opens in a new tab)OJ L 151, 7.6.2019 · EUR-Lex reuse under Commission Decision 2011/833/EU (© European Union)
- Directive (EU) 2016/2102 (Web Accessibility Directive) (opens in a new tab)OJ L 327, 2.12.2016 · EUR-Lex reuse under Commission Decision 2011/833/EU (© European Union)
Retrieved 2026-10-25
Feedback on this report
Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.
Reviews of this site
Share your experience with biochemtron.com. Every review is verified by email and published after moderation.
Community rating
No published reviews yet. Be the first to review biochemtron.com.